Header Logo

Lucila Garcia-Contreras

Concepts (187)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thiones
9
2020
55
4.350
Why?
Chromans
9
2020
59
3.880
Why?
Lung
18
2018
378
3.190
Why?
Antitubercular Agents
8
2016
16
2.320
Why?
Aerosols
15
2018
43
2.130
Why?
Uterine Cervical Dysplasia
3
2020
35
1.790
Why?
Administration, Inhalation
18
2018
35
1.640
Why?
Mycobacterium tuberculosis
6
2017
31
1.450
Why?
Pharmaceutical Preparations
5
2015
46
1.410
Why?
Drug Delivery Systems
11
2017
225
1.370
Why?
Antineoplastic Agents
4
2020
679
1.030
Why?
Chemistry, Pharmaceutical
8
2017
27
0.920
Why?
Suppositories
3
2020
7
0.890
Why?
Cyclin D1
3
2018
38
0.880
Why?
Guinea Pigs
15
2016
73
0.870
Why?
Animals
32
2023
10370
0.860
Why?
Chromatography, High Pressure Liquid
3
2019
129
0.800
Why?
Administration, Oral
8
2020
188
0.770
Why?
Capreomycin
3
2012
3
0.740
Why?
Tuberculosis
3
2012
25
0.740
Why?
Powders
8
2019
19
0.680
Why?
Biological Availability
6
2020
44
0.650
Why?
Chromatography, Reverse-Phase
1
2019
9
0.630
Why?
Antibiotics, Antitubercular
3
2007
4
0.620
Why?
Tuberculosis, Pulmonary
2
2010
6
0.610
Why?
Colistin
1
2018
3
0.610
Why?
Diestrus
1
2018
2
0.600
Why?
Estrus
1
2018
23
0.600
Why?
Tobramycin
1
2018
13
0.600
Why?
Particle Size
8
2019
101
0.580
Why?
Tuberculosis Vaccines
3
2012
6
0.550
Why?
Drug Carriers
5
2013
115
0.550
Why?
Ethionamide
1
2016
1
0.540
Why?
Technology, Pharmaceutical
3
2013
9
0.540
Why?
Nanoparticles
4
2013
287
0.500
Why?
Bronchoalveolar Lavage Fluid
6
2013
26
0.480
Why?
Tuberculosis, Multidrug-Resistant
2
2012
4
0.470
Why?
Lung Diseases
1
2015
43
0.450
Why?
Administration, Intravaginal
3
2018
12
0.450
Why?
Mice
8
2023
4621
0.440
Why?
Azepines
1
2013
2
0.440
Why?
Anti-Bacterial Agents
1
2018
520
0.430
Why?
Nebulizers and Vaporizers
4
2013
12
0.430
Why?
Hypoglycemic Agents
3
2003
106
0.410
Why?
Nitroimidazoles
2
2010
6
0.410
Why?
Cystic Fibrosis
2
2003
32
0.390
Why?
Nanomedicine
1
2013
62
0.390
Why?
Insulin
3
2003
315
0.390
Why?
Spleen
5
2013
112
0.390
Why?
Models, Animal
3
2007
129
0.360
Why?
Rifampin
2
2009
7
0.350
Why?
Half-Life
3
2020
34
0.340
Why?
Humans
17
2023
27968
0.320
Why?
Models, Biological
3
2020
466
0.320
Why?
Female
11
2023
15074
0.310
Why?
Area Under Curve
2
2020
95
0.310
Why?
Bacterial Vaccines
2
2010
29
0.310
Why?
Solubility
2
2019
73
0.300
Why?
X-Ray Diffraction
2
2019
41
0.300
Why?
Absorption
4
2013
14
0.300
Why?
Desiccation
2
2019
5
0.290
Why?
Dry Powder Inhalers
2
2018
3
0.290
Why?
Dose-Response Relationship, Drug
2
2020
604
0.280
Why?
Immunization
1
2008
119
0.280
Why?
Drug-Related Side Effects and Adverse Reactions
2
2013
67
0.260
Why?
Male
10
2019
13424
0.260
Why?
Ovarian Neoplasms
2
2023
588
0.240
Why?
Genetic Therapy
2
2003
123
0.240
Why?
Microspheres
5
2010
49
0.230
Why?
Amino Acids
2
2001
82
0.230
Why?
Reproducibility of Results
2
2019
769
0.220
Why?
Drug Compounding
4
2018
30
0.200
Why?
Disease Models, Animal
3
2012
1454
0.190
Why?
Exosomes
1
2023
96
0.180
Why?
Limit of Detection
2
2019
25
0.180
Why?
Toxicity Tests
1
2001
10
0.180
Why?
Administration, Intravenous
2
2020
30
0.180
Why?
Acetonitriles
1
2019
2
0.160
Why?
Liquid-Liquid Extraction
1
2019
3
0.160
Why?
Freeze Drying
1
2019
10
0.160
Why?
Gastric Acid
1
2019
19
0.160
Why?
Cervix Uteri
1
2018
64
0.150
Why?
Tissue Distribution
2
2020
136
0.150
Why?
Polyglycolic Acid
4
2010
38
0.140
Why?
Spectroscopy, Fourier Transform Infrared
1
2017
36
0.140
Why?
Lactic Acid
4
2010
92
0.140
Why?
Antigens, Bacterial
2
2010
161
0.140
Why?
Porosity
1
2016
38
0.130
Why?
Injections, Subcutaneous
2
2013
60
0.120
Why?
Bacterial Proteins
2
2010
484
0.120
Why?
Time Factors
2
2018
1590
0.120
Why?
Injections, Intramuscular
2
2012
22
0.110
Why?
Organ Size
2
2006
86
0.110
Why?
Calibration
1
2013
28
0.110
Why?
Mucociliary Clearance
1
2013
3
0.110
Why?
Transcytosis
1
2013
4
0.110
Why?
Treatment Outcome
2
2012
2367
0.110
Why?
Infusions, Intravenous
1
2013
102
0.110
Why?
Quality of Life
1
2017
484
0.110
Why?
Instillation, Drug
3
2001
7
0.100
Why?
Chromatography, Liquid
1
2013
76
0.100
Why?
Biological Transport
1
2013
121
0.100
Why?
Forecasting
1
2013
76
0.100
Why?
Cell Culture Techniques
1
2013
116
0.100
Why?
Rats, Sprague-Dawley
3
2003
550
0.100
Why?
Equipment Design
1
2013
217
0.100
Why?
Software
1
2013
125
0.100
Why?
Hypersensitivity, Delayed
2
2010
4
0.100
Why?
Phenylthiourea
1
2011
1
0.100
Why?
Spectrophotometry, Ultraviolet
1
2011
54
0.090
Why?
Drug Stability
3
2011
23
0.090
Why?
Drug Administration Schedule
1
2012
223
0.090
Why?
Immunity, Cellular
2
2010
23
0.090
Why?
Respiratory Function Tests
2
2001
27
0.090
Why?
Diphtheria Toxin
1
2010
6
0.090
Why?
Age Factors
1
2013
733
0.090
Why?
Hepatitis B Antigens
1
2010
1
0.090
Why?
Rats
3
2003
1570
0.090
Why?
Extensively Drug-Resistant Tuberculosis
1
2010
1
0.080
Why?
Latent Tuberculosis
1
2010
1
0.080
Why?
Colony Count, Microbial
1
2010
81
0.080
Why?
Infant, Newborn
1
2013
867
0.080
Why?
Infant
1
2013
987
0.080
Why?
Acetylmuramyl-Alanyl-Isoglutamine
1
2009
2
0.080
Why?
Adjuvants, Immunologic
1
2009
67
0.080
Why?
Tuberculin
1
2008
1
0.070
Why?
Mycobacterium smegmatis
1
2008
2
0.070
Why?
Drug Administration Routes
1
2008
8
0.070
Why?
BCG Vaccine
1
2008
13
0.070
Why?
Leucine
1
2008
20
0.070
Why?
Humidity
1
2008
7
0.070
Why?
Microbial Viability
1
2008
29
0.070
Why?
Polyglactin 910
1
2007
2
0.070
Why?
Mucous Membrane
1
2007
28
0.070
Why?
Cell Line, Tumor
2
2023
1314
0.070
Why?
Microscopy, Electron, Scanning
4
2010
73
0.070
Why?
Acyltransferases
1
2007
24
0.070
Why?
Drug Design
1
2007
63
0.070
Why?
CD4-Positive T-Lymphocytes
1
2007
106
0.070
Why?
Zidovudine
2
1996
2
0.060
Why?
Enzyme-Linked Immunosorbent Assay
3
2010
256
0.060
Why?
Intubation, Intratracheal
2
2001
27
0.060
Why?
Swine
2
2001
236
0.050
Why?
Tropism
1
2023
8
0.050
Why?
Adenoviridae
1
2003
67
0.050
Why?
Genetic Vectors
1
2002
114
0.050
Why?
L-Lactate Dehydrogenase
1
2001
19
0.050
Why?
Alkaline Phosphatase
1
2001
31
0.050
Why?
Insufflation
1
2001
1
0.050
Why?
Pharmacokinetics
1
2001
1
0.050
Why?
Positive-Pressure Respiration
1
2001
14
0.040
Why?
Randomized Controlled Trials as Topic
1
2003
381
0.040
Why?
Species Specificity
1
2001
191
0.040
Why?
Mice, Nude
1
2020
330
0.040
Why?
Xenograft Model Antitumor Assays
1
2020
268
0.040
Why?
Food, Formulated
1
2017
11
0.040
Why?
Emulsifying Agents
1
2017
7
0.040
Why?
Chemoprevention
1
2017
32
0.040
Why?
Recombinant Proteins
2
2010
412
0.040
Why?
Cell Line
2
2009
695
0.030
Why?
Delayed-Action Preparations
2
2007
43
0.030
Why?
Mice, Inbred C57BL
1
2017
1561
0.030
Why?
Surface Properties
2
2007
134
0.020
Why?
Reference Standards
1
2011
57
0.020
Why?
Neutralization Tests
1
2010
34
0.020
Why?
Hepatitis B Antibodies
1
2010
2
0.020
Why?
Antibodies, Bacterial
1
2010
102
0.020
Why?
Trehalose
1
2009
3
0.020
Why?
Macrophage Activation
1
2009
32
0.020
Why?
Drug Discovery
1
2009
34
0.020
Why?
Macrophages, Alveolar
1
2009
36
0.020
Why?
Monocytes
1
2009
135
0.020
Why?
Hybridomas
1
2007
17
0.020
Why?
Injections, Intravenous
1
2007
65
0.020
Why?
Interleukin-2
1
2007
34
0.020
Why?
Cell Survival
1
2009
408
0.020
Why?
Cloning, Molecular
1
2007
205
0.020
Why?
Antigen Presentation
1
2007
78
0.020
Why?
Lymphocyte Activation
1
2007
209
0.020
Why?
Kinetics
1
2007
544
0.020
Why?
Macrophages
1
2007
292
0.010
Why?
Escherichia coli
1
2007
337
0.010
Why?
Blood Glucose
1
2001
309
0.010
Why?
Mathematical Computing
1
1996
4
0.010
Why?
Evaluation Studies as Topic
1
1996
43
0.010
Why?
Models, Chemical
1
1996
90
0.010
Why?
Predictive Value of Tests
1
1996
474
0.010
Why?
Garcia-Contreras's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (187)
Explore
_
Co-Authors (10)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_